Skip to content

AHC Ballana Heart Study

Aswan Heart Centre - Ballana Heart Study

Status
Recruiting
Phases
Unknown
Study type
Observational
Source
ClinicalTrials.gov
Registry ID
NCT05661318
Acronym
AHC-BHS
Enrollment
5000
Registered
2022-12-22
Start date
2018-01-01
Completion date
2055-01-31
Last updated
2024-05-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Genetic Predisposition to Disease

Keywords

genetics, Cardiovascular risks

Brief summary

This Study is designed to assess CVD incidence, prevalence, progression and related risk factors, including genetic background. It will provide an important base for all cardiovascular research activities in our centre and help in designing future studies and guide policy.

Detailed description

Background Population-based longitudinal studies are a cornerstone in understanding current disease landscapes affecting communities and collecting reliable data to guide prevention and treatment strategies. In Egypt there is pressing need of collecting reliable data on cardiovascular disease (CVD) in defined populations. Objectives Defining the cardiovascular phenotype, genotype as well as OMICS and risk factors for CVD in a defined population in Egypt with follow up for up to 30 years Methods As a first step, a random representative sample of 1,200 households from the Ballana population will be created. Following inclusion, patients will be screened for their cardiovascular profile and followed up for changes in their profile and cardiovascular events continuously every year in high risk patients and every 3 years for the rest of the participants for a period of 30 years.

Interventions

OTHERRisk assessment

Collect clinical, laboratoary and genetics data from the participants after informed consent

Sponsors

Magdi Yacoub Heart Foundation
Lead SponsorOTHER

Study design

Observational model
ECOLOGIC_OR_COMMUNITY
Time perspective
PROSPECTIVE

Eligibility

Sex/Gender
ALL
Age
18 Years to No maximum
Healthy volunteers
Yes

Inclusion criteria

* Residents of Ballana from the 1,200 randomly selected households * Participants must have a valid National ID card * Written informed consent

Exclusion criteria

• Residents who are younger than 18 years

Design outcomes

Primary

MeasureTime frame
Cardiovascular risk assessment30 years

Countries

Egypt

Contacts

Primary ContactYasmine Aguib, PhD
yasmine.aguib@aswanheartcentre.com+201092036368
Backup ContactAhmed Elguindy, MD
ahmed.elguindy@aswanheartcentre.com+201001615151

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026